SEATTLE, March 15 /PRNewswire/ - Dr. Bojana Turic, Vice President, COO will present on behalf of Perceptronix Medical Inc. ("Perceptronix") at the Invest Northwest CEO & Investor Forum on March 20 at Bell Harbor International Conference Center, Seattle, Washington. Organized by the Washington Biotechnology & Biomedical Association (WBBA) in collaboration with BC Biotech, BC Medtech, BioAlberta, BioIdaho, Montana Bioscience Alliance and the Oregon Bioscience Association, Invest Northwest is in its sixth year.
The annual life science CEO and investor conference will include presentations from 57 of the region's top medical device and biotechnology companies. "I am looking forward to presenting along side such an outstanding group of companies" says Dr. Turic. "The conference is not only an exciting opportunity for us to inform investors on our business and platforms but it is also an excellent forum to explore synergies with other companies."
About Perceptronix Medical Inc. (www.perceptronix.com)
Perceptronix Medical Inc. (founded in 1999) is a private cancer diagnostics company based in Vancouver, Canada. Perceptronix commercializes early cancer detection technologies developed in partnership with the BC Cancer Agency, a world-leader in cancer care and research, with a particularly notable track record in pioneering early cancer detection programs. Perceptronix' products and services offer an improvement over existing detection and localization technologies and provide physicians with increased options for prolonging and improving the quality of patients' lives.
About Invest Northwest
To qualify as a presenting company, a firm must be based in the Pacific Northwest and have biosciences as its business base. Invest Northwest is a forum for senior executives from selected public and private life sciences companies based in the Pacific Northwest to tell their stories to institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors and prospective corporate partners. More than 500 people are expected to attend the forum, now in its sixth year. For more information, visit www.washbio.org.
This news release is not, and under no circumstances, to be construed as, an advertisement, solicitation or offering of securities of Perceptronix Medical Inc. The statements made in this news release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations.
CONTACT: Dr. Bojana Turic, Vice President, COO Perceptronix Medical Inc., Phone: (604) 629-8785, info@perceptronix.com; Media Contact: Amanda Smith, BSc, Smith Biotech, Phone: (778) 846-4116, amanda@smithbiotech.com
Perceptronix Medical Inc.CONTACT: Dr. Bojana Turic, Vice President, COO Perceptronix Medical Inc.,Phone: (604) 629-8785, info@perceptronix.com; Media Contact: Amanda Smith,BSc, Smith Biotech, Phone: (778) 846-4116, amanda@smithbiotech.com
